Efficacy of Haemate-P as prophylaxis of recurrent bleeding in a patient with type 2B von Willebrand's disease

Blood Coagul Fibrinolysis. 2005 Nov;16(8):571-2. doi: 10.1097/01.mbc.0000187249.25006.15.

Abstract

We report the case of a 58-year-old woman with type 2B von Willebrand's disease who received regular infusions of the factor VIII/von Willebrand factor concentrate Haemate-P (2000 IU every other day) for 4 months to prevent recurrent bleeding from a malignant esophageal ulcer. Prophylaxis with Haemate-P was shown to be safe and effective in this patient, thus enabling completion of radiochemotherapy.

Publication types

  • Case Reports

MeSH terms

  • Esophageal Neoplasms / complications*
  • Esophageal Neoplasms / radiotherapy
  • Factor VIII / administration & dosage*
  • Female
  • Hemorrhage / etiology*
  • Hemorrhage / prevention & control*
  • Humans
  • Middle Aged
  • von Willebrand Diseases / complications*
  • von Willebrand Diseases / drug therapy
  • von Willebrand Factor / administration & dosage*

Substances

  • von Willebrand Factor
  • F8 protein, human
  • Factor VIII